Vanguard Asset Management
WGS icon

Vanguard Asset Management’s GeneDx Holdings WGS Stock Holding History

Vanguard Asset Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$913K Hold
13,294
– – ﹤0.01% 1926
2026
Q1 		$854K Buy
+13,294
New +$1.21M ﹤0.01% 1861

Other funds holding WGS

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Asset Management's WGS Position: Q2 2026 in Review

Vanguard Asset Management held its GeneDx Holdings (WGS) position steady in Q2 2026 at 13,294 shares worth $913K. The position accounts for ﹤0.01% of the portfolio, ranked #1926.

Vanguard Asset Management first reported a position in WGS in Q1 2026 and has held it in 2 quarters since. 204 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Vanguard Asset Management held 13,294 shares of GeneDx Holdings worth $913K as of Q2 2026.
  • Vanguard Asset Management left its GeneDx Holdings share count unchanged in Q2 2026.
  • GeneDx Holdings made up ﹤0.01% of Vanguard Asset Management's portfolio in Q2 2026, its #1926 holding.
  • Vanguard Asset Management first reported a position in GeneDx Holdings in Q1 2026 and has held it in 2 quarters since.
  • 204 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.